公司資料
10x Genomics 股價、新聞與催化劑
- 股票代碼:
- TXG
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
57.99 USD (+3.39%)
收盤價
最後更新: 2026年8月17日
3.9B USD
市值
股價為何變動
As of Aug 17, 2026, TXG closed up 3.39% at $57.99. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
10x Genomics is a life sciences tools company focused on single-cell and spatial biology technologies. Its products help researchers study biology at high resolution and support discovery across genomics and translational research.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, 10x Genomics has a global footprint in research tools. It sits in the biotech infrastructure layer rather than therapeutics.
商業模式特徵
The company generates revenue from instruments, consumables, and workflow technologies used in genomics research. Investors watch academic and biopharma spending, product adoption, and the pace of platform utilization.
生技產業定位
10x Genomics is one of the most important tools names in modern biology because it powers discovery across the life sciences. It is not a drug company, but it is highly relevant to biotech research spending.
未來催化劑
- 10x Genomics’ catalysts are Xenium adoption, Chromium demand, and any evidence that consumables recovery is finally broadening. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。